Quarterly report pursuant to Section 13 or 15(d)

Share Holders Equity (Deficit) (Details)

v3.20.1
Share Holders Equity (Deficit) (Details) - Warrant - $ / shares
3 Months Ended
Mar. 31, 2020
Dec. 31, 2019
Sep. 30, 2019
Number of Shares      
Warrants outstanding, beginning balance (in shares) 30,527,776    
Number of warrants granted, marathon debt (in shares) 34,293    
Number of warrants exercised (in shares) (173,809)    
Number of warrants expired (in shares) (43,157)    
Warrants outstanding, ending balance (in shares) 30,345,103    
Weighted Average Exercise Price per Warrant      
Weighted average exercise price per warrant , ending balance (in usd per share) $ 1.82 $ 1.82 $ 1.82
Weighted average exercise price per warrant granted, marathon debt (in usd per share) 1.78    
Weighted average exercise price per warrant, exercised (in usd per share) 1.59    
Weighted average exercise price per warrant, expired (in usd per share) $ 1.40